Grants

Our Grantmaking in 2018

  • Total

    $33,013,000

    Click on the diagram sections for information specific to each of our priority areas listed below.

    View grantmaking in 2017
  • Priority Area

    Multiple Sclerosis

    $0

    This amount represents our total giving for seeking a cure and improving quality of life for those who live with multiple sclerosis.

    About Priority
  • Priority Area

    Substance Use Prevention

    $2,350,000

    This amount represents our total giving for youth substance use prevention and early intervention.

    About Priority
  • Priority Area

    Avoidable Blindness

    $0

    This amount represents our total giving for preventing avoidable sight loss from cataracts and blinding trachoma.

    About Priority
  • Priority Area

    Hospitality

    $1,500,000

    This amount represents our total giving for building career pathways for youth in the hospitality sector

    About Priority
  • Priority Area

    Disaster Relief & Recovery

    $0

    This amount represents our total giving for supporting disaster preparedness, relief, and long-term recovery.

    About Priority
  • Priority Area

    Other

    $0

    This amount represents our total giving for non-priority grantmaking which includes small and matching discretionary grant programs for board members, staff and members of the Hilton family.

    View 2018 grants
  • Priority Area

    Homelessness

    $2,000,000

    This amount represents our total giving for ending chronic homelessness in Los Angeles County.

    About Priority
  • Priority Area

    Catholic Sisters

    $1,465,000

    This amount represents our total giving for building a global Catholic sisterhood to advance human development.

    About Priority
  • Priority Area

    Catholic Education

    $2,850,000

    This amount represents our total giving for revitalizing Catholic schools serving low-income families.

    About Priority View 2018 grants
  • Priority Area

    Young Children Affected by HIV and AIDS

    $5,000,000

    This amount represents our total giving for the year to date for improving early childhood development outcomes for young children affected by HIV and AIDS.

    About Priority View 2018 grants
  • Priority Area

    Foster Youth

    $6,595,000

    This amount represents our total giving for the year to date for achieving healthy and productive lives for transition age youth in foster care.

    About Priority View 2018 grants
  • Priority Area

    Safe Water

    $11,253,000

    This amount represents our total giving for increasing access to safe water for vulnerable and disadvantaged communities.

    About Priority View 2018 grants
  • Young Children Affected by HIV and AIDS

  • Multiple Sclerosis

  • Safe Water

  • Avoidable Blindness

  • Homelessness

  • Catholic Sisters

  • Substance Use Prevention

  • Foster Youth

  • Disaster Relief & Recovery

  • Other

  • Catholic Education

  • Hospitality

This total represents grant payment activity during the selected fiscal year. However, approximately 90% of the money awarded in our priority program areas is part of multi-year commitments, so a grant may appear in multiple years of activity. The list below provides additional information about specific projects approved and/or paid during the fiscal year selected, including the project start date and the length of our commitment.

  1. Regents of the University of California Los Angeles

    $185,000 through October 2018

    to support planning for a phase III clinical trial of estriol. http://www.research.ucla.edu

    Multiple Sclerosis USA Awarded: November 2017
  2. J. David Gladstone Institutes

    $405,000 through October 2019

    to support research on the coagulation cascade as a biomarker for progressive multiple sclerosis. www.gladstoneinstitutes.org

    Multiple Sclerosis USA Awarded: November 2017
  3. National Institutes of Health

    $74,062 through June 2019

    to identify new biomarkers of inflammation and neurodegeneration using the plasma of patients with MS. www.nih.gov

    Multiple Sclerosis USA Awarded: October 2017
  4. Icahn School of Medicine at Mount Sinai

    $117,584 through June 2021

    to study astrocytic regulation of immune cell activity during central nervous system inflammation. http://icahn.mssm.edu

    Multiple Sclerosis USA Awarded: May 2017
  5. National Institutes of Health

    $585,000 through June 2022

    to study how to reduce chronic inflammation in MS patients. www.nih.gov

    Multiple Sclerosis USA Awarded: May 2017
  6. Regents of the University of Colorado

    $120,000 through June 2019

    to study mechanisms regulating MS-related myelin injury and repair in cortical lesions. http://www.ucdenver.edu

    Multiple Sclerosis USA Awarded: May 2017
  7. Baylor College of Medicine

    $120,000 through June 2019

    to study how targeting the Wnt receptor complex may increase myelin repair in MS patients. www.bcm.edu

    Multiple Sclerosis USA Awarded: May 2017
  8. Regents of the University of California, Irvine

    $120,000 through June 2019

    to study whether lower GlcNAc levels promote the progression of MS by preventing oligodendrocyte formation and reducing remyelination. http://www.research.uci.edu

    Multiple Sclerosis USA Awarded: May 2017
  9. Massachusetts General Hospital

    $120,000 through June 2019

    to develop imaging markers of axonal damage and myelin integrity in MS patients using ultra-high gradient MRI techniques. http://www.massgeneral.org/

    Multiple Sclerosis USA Awarded: May 2017
  10. Vanderbilt University Medical Center

    $120,000 through June 2019

    to apply advanced imaging to the study of the cervical spinal cord in patients with MS. https://www.mc.vanderbilt.edu

    Multiple Sclerosis USA Awarded: May 2017
  11. Washington University

    $120,000 through June 2019

    to identify biomarkers in cerebrospinal fluid that may predict MS disease progression and responses to therapy. http://www.wustl.edu

    Multiple Sclerosis USA Awarded: May 2017
  12. University of Southern California

    $120,000 through June 2019

    to study the potential of angiotensin 1-7 to promote oligodendrocyte progenitor cell remyelination. http://www.usc.edu

    Multiple Sclerosis USA Awarded: May 2017
  13. Johns Hopkins University

    $535,000 through June 2021

    to study signaling pathways that lead to free radical damage in MS patients. http://www.jhu.edu

    Multiple Sclerosis USA Awarded: May 2017
  14. Johns Hopkins University

    $552,710 through September 2021

    to use advanced imaging techniques to study what role astrocytes cells in the cortex may play in promoting remyelination in MS. http://www.jhu.edu

    Multiple Sclerosis USA Awarded: May 2017
  15. Johns Hopkins University

    $45,938 through June 2019

    to identify new biomarkers of inflammation and neurodegeneration using the plasma of patients with MS. http://www.jhu.edu

    Multiple Sclerosis USA Awarded: May 2017
  16. University of California, San Francisco

    $120,000 through June 2019

    to study misfolded tau aggregates found in the brains of MS patients. http://www.ucsf.edu

    Multiple Sclerosis USA Awarded: May 2017
  17. Case Western Reserve University

    $120,000 through June 2018

    to study the unifying mechanisms all remyelinating molecules have in common and to share findings with the field of MS research. https://case.edu/

    Multiple Sclerosis USA Awarded: May 2017
  18. New York Stem Cell Foundation, Inc.

    $120,000 through June 2019

    to study the properties of oligodendrocyte progenitor cells in MS. http://www.nyscf.org

    Multiple Sclerosis USA Awarded: May 2017
  19. University of California, San Francisco

    $120,000 through June 2019

    to develop an innovative neuroimaging method that will detect oxidative stress in patients with MS. http://www.ucsf.edu

    Multiple Sclerosis USA Awarded: May 2017
  20. University of California, San Francisco

    $120,000 through June 2019

    to support a retinal method study of innate immune activation in MS, with a goal of advancing targeted therapeutic approaches. http://www.ucsf.edu

    Multiple Sclerosis USA Awarded: May 2017